腹腔镜腹股沟淋巴结清扫术4例报告  

Laparoscopic inguinal lymphadenectomy for penile cancer(Report of four cases)

作　　者：丁亚飞[1] 顾朝辉[1] 贾占奎[1] 邢伟只 何涛[1] 范新磊[1] 方楚言[2] 曾甫清[3] 杨锦建[1] 

机构地区：[1]郑州大学第一附属医院泌尿外科,河南省泌尿外科研究所,郑州市泌尿外科肿瘤分子生物学重点实验室,郑州450052 [2]河南大学人民武装学院 [3]华中科技大学同济医学院附属协和医院泌尿外科

出　　处：《临床泌尿外科杂志》2014年第1期7-9,共3页Journal of Clinical Urology

基　　金：国家自然科学基金项目(编号81100464/H0424;编号81200883/H0905);中国博士后科学基金(编号2012M521410);河南省卫生厅科技攻关项目(编号2011020039)

摘　　要：目的：探讨阴茎癌治疗中腹腔镜腹股沟淋巴结清扫术的有效性、安全性及围手术期处理。方法：对4例行腹腔镜双侧腹股沟淋巴结清扫术的阴茎癌患者临床资料进行回顾性分析，统计手术时间、术中出血量、术后住院时间及并发症，评价其安全性和有效性。结果：4例患者均成功实施腹腔镜双侧腹股沟淋巴结清扫术，无一例中转开放手术。平均出血量30（20～50）ml，平均手术时间248（233-272）min，平均清扫淋巴结18（13～23）个，术后平均住院时间9（8～12）d。1例患者出现穿刺位点愈合延迟，余未发生其他并发症。结论：腹腔镜腹股沟淋巴结清扫术是一种安全、可行的手术方式，与开放手术相比，具有手术时间短、出血量少，并发症少、恢复快、术后住院时间短等优势，尤其可避免皮瓣坏死、皮下血肿。Objective： To explore the efficiency and safety of laparoscopic inguinal lymphadenectomy for penile cancer and to discuss perioperative management. Method： The clinical data of four cases underwent laparoscopic bilateral inguinal lymphadenectomy were analyzed retrospectively, including operation time, intraoperative blood loss, postoperative hospital stay, and the incidence of complications in orderd to evaluate its safety and effective- ness. Result： Four patients with laparoscopic bilateral inguinal lymphadenectomy were successful without conver- sion to open surgery. The average blood loss was 30 （range, 20-50） ml. The average operation time was 248 （range, 233-272） min. The average number of reseeted lymph node was 18 （range, 13-23）. The average postop- erative hospital stay was 9 （range, 8-12） d. Except for one case of prolonged healing of the puncture point, other complications didn＇t appear. Conclusion.. Laparoscopic inguinal lymphadenectomy is safe and feasible. It has some merits of shorter operation time, less blood loss, low incidence of complication, rapid recovery and shorter postop- erative hospital stay compared with the open surgery. Such procedure could especially avoid skin flap necrosis and subcutaneous hematoma.

关 键 词：阴茎癌 腹腔镜 腹股沟淋巴结清扫术 

分 类 号：R737.27[医药卫生—肿瘤]